On September 27, 2021 Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, reported that it will participate in the following investor conferences (Press release, Dynavax Technologies, SEP 27, 2021, https://investors.dynavax.com/news-releases/news-release-details/dynavax-present-upcoming-investment-conferences [SID1234590297]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
2021 Cantor Virtual Global Healthcare Conference
Dynavax Presentation: Thursday, September 30, 2021, 12:00 p.m. E.T.
Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
Fireside Chat: Tuesday, October 5, 2021, 12:00 p.m. E.T.
H.C. Wainwright 2nd Hepatitis B Virus (HBV) Virtual Conference
Fireside Chat: Wednesday, October 13, 2021, 12:00 p.m. E.T.
All the conferences are being held virtually. A live webcast of each of the presentations will be available and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company’s website at View Source